[1] |
Amin MB, Frederick LG, Stephen BE, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging [J]. CA Cancer J Clin, 2017, 67: 93-99.
|
[2] |
Dasari A, Chan S, Daniel H, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States[J]. JAMA Oncol, 2017, 3: 1335-1342.
|
[3] |
Takizawa N, Ohishi Y, Hirahashi M, et al. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocr-ine tumor[J]. Hum Pathol, 2015, 46: 1890-900.
|
[4] |
Klimstra DS, Capella C, Arnold R, et al. Neuroendocrine neoplasms of the colon and rectum. In: Bosaman FT, et al, editors. WHO classification of tumors of the digestive system[M]. Lyon, France: IARC Press; 2010: 174-177.
|
[5] |
Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system[M]. WHO Classification of Tumours of the Digestive System 4th edn. Lyon: International Agency for Research on Cancer(IARC); 2010: 13-14.
|
[6] |
La Rosa S, Marando A, Furlan D,et al. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers[J]. Am J Surg Pathol, 2012, 36: 601-611.
|
[7] |
Liu S, Chang Y, Ma J, et al. Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors[J]. Oncol Lett, 2013, 6: 1641-1645.
|
[8] |
Pizzi S, Azzoni C, Tamburini E, et al. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability[J]. Endocr Relat Cancer, 2008, 15: 1013-1024.
|
[9] |
Vortmeyer AO, Lubensky IA, Merino MJ, et al. Concordance of genetic alterations in poorly differentiated colorec-tal neuroendocrine carcinomas and associated adenocarcinomas[J]. J Natl Cancer Inst, 1997, 89: 1448-1453.
|
[10] |
Woischke C, Schaaf CW, Yang HM, et al. In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components[J]. Mod Pathol, 2017, 30: 95-103.
|
[11] |
Wang TT, Lu J, Xu L, et al. Whole genome sequencing of colorectal neuroendocrine tumors and in-depth muta-tional analyses[J]. Med Oncol, 2020, 37: 56. doi: 10.1007/s12032-020-01356-y.
|
[12] |
Scarpa A, Chang DK, Nones K, et al. Whole-genome landscape of pancreatic neuroendocrine tumours[J]. Nature, 2017, 543: 65-71.
|
[13] |
Hong X, Qiao S, Li F, et al. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classifcation system[J]. Gut, 2020, 69: 877-887.
|